Brianna Abbott

Immune-boosting drugs extend cancer patients’ lives and deliver billions in sales to drugmakers, but some patients might be getting more of the drugs than they need.

Covid is surging again, four years after the pandemic began, as a new virus subvariant becomes dominant in the U.S. and as people gather indoors to escape cold weather.

Researchers are trying to figure out what is making more young adults sick, and how to identify those at high risk

米国ではがんの治療で進歩がみられる半面、予防に関しては遅れている。

Diagnosis rates in the U.S. rose in 2019 to 107.8 cases per 100,000 people under 50, up 12.8% from 95.6 in 2000, federal data show

Recent movies feature characters bursting into song, a move that some viewers didn’t expect. ‘There was no warning.’

Recent movies feature characters bursting into song, a move that some viewers didn’t expect. ‘There was no warning.’

Uterine cancer will kill some 13,250 women in the U.S. this year, surpassing ovarian cancer to become the deadliest gynecologic cancer. And the reasons aren't entirely clear.

More patients can fend off the disease for months or years with targeted or immune-boosting drugs, results released this weekend at a top cancer conference showed.

There is more hope than ever for people diagnosed with the deadliest cancer.